Aehr Test Systems Director Liquidates Portion of Holdings Amid Record AI Order

Fariba Danesh, a member of the Board of Directors at Aehr Test Systems (NASDAQ: AEHR), has reduced her direct equity stake by approximately 37.8%. According to SEC Form 4 filings, Danesh sold 8,000 shares on April 16, 2026, for a total transaction value of roughly $661,000. The shares were acquired through the exercise of expiring stock options and were immediately disposed of on the open market. The liquidation occurred during a period of significant price appreciation for the company. Aehr's stock reached a 52-week peak of $91.43 on the day of the sale, driven by the announcement of a $41 million production order from an AI hyperscale customer. This represents the largest single production order in the company's history, reflecting the surging global demand for semiconductor testing equipment tailored for artificial intelligence applications. Despite the positive momentum from the hyperscale order, the company's recent financial statements reveal a contraction in top-line growth. For the fiscal third quarter ending February 27, Aehr reported sales of $10.3 million, a sharp decline from the $18.3 million reported in the same period the previous year. From a valuation perspective, the stock is currently trading at a premium, with a price-to-sales ratio exceeding 55. While the record order suggests a potential inflection point for future revenue, the combination of high valuation and insider selling may indicate a short-term ceiling for the equity's price action.